NewsFDA AdCom votes unanimously in favor of GSK myeloma drug, despite earlier agency skepticismadminJuly 18, 2020 by adminJuly 18, 2020029A panel of experts convened by the Food and Drug Administration has voted in favor of a GlaxoSmithKline drug for relapsed and refractory multiple myeloma...
